Leading transplant experts share vital information to help you make informed healthcare decisions before and after transplant.
Graft-versus-host disease (GVHD) is a common complication after a bone marrow or stem cell transplant that uses donor cells (allogeneic transplant). Learn about the two types of GVHD, organs they affect, and therapies available to prevent and treat GVHD.
La Enfermedad de Injerto contra Huésped (EICH) es una complicación común después de un trasplante de médula ósea o de células madre que utiliza células de un donante (trasplante alogénico). Conozca qué órganos suele afectar y las opciones de tratamiento.
Graft-versus-host disease (GVHD) is a common complication after a bone marrow or stem cell transplant using donor cells (allogeneic transplant) and can be difficult to treat. Learn about new therapies to prevent and treat GVHD.
Este video informa acerca de los avances en la prevención y el tratamiento de la enfermedad de injerto contra huésped aguda y crónica, así como sobre las drogas que han sido aprobadas por el FDA y algunos ensayos clínicos que se están desarrollando actualmente.
Family caregivers for patients with graft-versus-host disease (GVHD) deal with physical and emotional challenges that are often overlooked by family, friends and healthcare providers. Five steps can help caregivers build resilience for the GHVD "journey".
The family caregiver plays a vital role in the patient’s recovery.
Learn More
Learn how to help your child through the transplant experience.
Learn More
GVHD is a common problem after a transplant using donor cells.
Learn More